Skip Nav Destination
IN THIS ISSUE
Modelling of a targeted nanotherapeutic ‘stroma’ to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt–β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson’s disease
Jing-Wei Zhao,Sean C. Dyson,Christina Kriegel,Pam Tyers,Xiaoling He,Tarek M. Fahmy,Su M. Metcalfe,Roger A. Barker
Development of a physiologically relevant and easily scalable LUHMES cell-based model of G2019S LRRK2 driven parkinson's disease
Barbara Calamini, Nathalie Geyer et al.
Mouse models for dominant dystrophic epidermolysis bullosa (DDEB) carrying common human point mutations recapitulate the human disease
B. R. C. Smith, A. Nystrom et al.
Lauren G. Falkenberg, Sarah A. Beckman et al.
Novel Drosophila central nervous system injury paradigm in adult: molecular, cellular and functional aspects
María Losada-Pérez, Nuria García-Guillén et al.
Reproductive history determines ErbB2 locus amplification, WNT signalling and tumour phenotype in a murine breast cancer model
Liliana D. Ordonez, Lorenzo Melchor et al.